These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19693635)

  • 21. BMP-7 versus BMP-2 for the treatment of long bone nonunion.
    Conway JD; Shabtai L; Bauernschub A; Specht SC
    Orthopedics; 2014 Dec; 37(12):e1049-57. PubMed ID: 25437077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis.
    Joseph V; Rampersaud YR
    Spine (Phila Pa 1976); 2007 Dec; 32(25):2885-90. PubMed ID: 18246013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?
    Mannion RJ; Nowitzke AM; Wood MJ
    Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model.
    Welch RD; Jones AL; Bucholz RW; Reinert CM; Tjia JS; Pierce WA; Wozney JM; Li XJ
    J Bone Miner Res; 1998 Sep; 13(9):1483-90. PubMed ID: 9738522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of tibial plateau fractures with an injectable bone substitute: CERAMENT™. Three year follow-up from a prospective study.
    Iundusi R; Gasbarra E; D'Arienzo M; Piccioli A; Tarantino U
    BMC Musculoskelet Disord; 2015 May; 16():115. PubMed ID: 25968241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone morphogenetic proteins in orthopaedic trauma: recent clinical findings with human bone morphogenetic protein-2 (rhBMP-2).
    Patel AD
    Curr Med Res Opin; 2006; 22 Suppl 1():S1-5. PubMed ID: 16882363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse events after recombinant human BMP2 in nonspinal orthopaedic procedures.
    Woo EJ
    Clin Orthop Relat Res; 2013 May; 471(5):1707-11. PubMed ID: 23132207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review.
    Garrison KR; Donell S; Ryder J; Shemilt I; Mugford M; Harvey I; Song F
    Health Technol Assess; 2007 Aug; 11(30):1-150, iii-iv. PubMed ID: 17669279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human bone morphogenic protein-2 in fracture care.
    Jones AL
    J Orthop Trauma; 2005; 19(10 Suppl):S23-5. PubMed ID: 16479219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients.
    Axelrad TW; Steen B; Lowenberg DW; Creevy WR; Einhorn TA
    J Bone Joint Surg Br; 2008 Dec; 90(12):1617-22. PubMed ID: 19043134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human bone morphogenic protein-7: applications for clinical trauma.
    McKee MD
    J Orthop Trauma; 2005; 19(10 Suppl):S26-8. PubMed ID: 16479220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications and results for the Exogen™ ultrasound system in the management of non-union: a 59-case pilot study.
    Roussignol X; Currey C; Duparc F; Dujardin F
    Orthop Traumatol Surg Res; 2012 Apr; 98(2):206-13. PubMed ID: 22424956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent developments in the use of bone morphogenetic protein in orthopaedic trauma surgery.
    Nordsletten L
    Curr Med Res Opin; 2006; 22 Suppl 1():S13-7; S23. PubMed ID: 16882365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome evaluation of staged treatment for bicondylar tibial plateau fractures.
    Giordano V; do Amaral NP; Koch HA; E Albuquerque RP; de Souza FS; Dos Santos Neto JF
    Injury; 2017 Oct; 48 Suppl 4():S34-S40. PubMed ID: 29145966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local BMP-2 application can rescue the delayed osteotomy healing in a rat model.
    Wildemann B; Lange K; Strobel C; Fassbender M; Willie B; Schmidmaier G
    Injury; 2011 Aug; 42(8):746-52. PubMed ID: 21134674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): early experience.
    Dohin B; Dahan-Oliel N; Fassier F; Hamdy R
    Clin Orthop Relat Res; 2009 Dec; 467(12):3230-8. PubMed ID: 19588211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Early Definitive Fixation of Bicondylar Tibial Plateau Fractures Safe? An Observational Cohort Study.
    Unno F; Lefaivre KA; Osterhoff G; Guy P; Broekhuyse HM; Blachut PA; OʼBrien P
    J Orthop Trauma; 2017 Mar; 31(3):151-157. PubMed ID: 28072649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications and outcomes of the transfibular approach for posterolateral fractures of the tibial plateau.
    Pires RES; Giordano V; Wajnsztejn A; Oliveira Santana E; Pesantez R; Lee MA; de Andrade MAP
    Injury; 2016 Oct; 47(10):2320-2325. PubMed ID: 27480912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoinductive effect of cerebrospinal fluid from brain-injured patients.
    Gautschi OP; Toffoli AM; Joesbury KA; Skirving AP; Filgueira L; Zellweger R
    J Neurotrauma; 2007 Jan; 24(1):154-62. PubMed ID: 17263679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.